U.S Food and Drug Administration Clears PositiveID's iglucose System for Diabetes Management

iglucose is a First-of-its-Kind Wireless Communication System for Diabetes Management

PositiveID to Begin Commercialization Efforts in First Quarter 2012

DELRAY BEACH, Fla., Nov. 16, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management and clinical diagnostics, announced today it has received clearance from the U.S. Food and Drug Administration ("FDA") for its iglucose™ mobile health system for diabetes management. iglucose uses mobile technology to revolutionize the way individuals with diabetes manage their condition. By seamlessly communicating glucose readings from data-capable glucometers to the iglucose diabetes management portal, this important data can be shared with family members, caregivers and healthcare professionals. This makes it possible to improve care in a cost-effective manner and help loved ones manage their diabetes. Read more...